Intestinal Fibrosis and Liver Fibrosis: Consequences of Chronic Inflammation or Independent Pathophysiology?
Intestinal Fibrosis and Liver Fibrosis: Consequences of Chronic Inflammation or Independent Pathophysiology?
复制标题
肠纤维化和肝纤维化:慢性炎症的后果还是独立的病理生理学?
DOI:
10.1159/000445135
复制
发表时间:
2016
影响因子:
--
通讯作者:
Inagaki,Yutaka
中科院分区:
文献类型:
--
作者:
Rieder,Florian;Bettenworth,Dominik;Imai,Jin;Inagaki,Yutaka
BackgroundIntestinal fibrosis and liver fibrosis represent a significant burden for our patients and health-care systems. Despite the severe clinical problem and the observation that fibrosis is reversible, no specific antifibrotic therapies exist.SummaryIn this review, using an ‘East-West'scientific collaboration, we summarize the current knowledge on principal mechanisms shared by intestinal fibrosis and liver fibrosis. We furthermore discuss inflammation as the cause of fibrogenesis in both entities, depict unique features of intestinal and hepatic fibrosis, and provide a future outlook on the development of antifibrotic therapies.Key MessagesA collaborative effort in the field of fibrosis, covering multiple organ systems, will have the highest chance of leading to the development of a successful antifibrotic intervention.
登录
查看更多内容
DOI:
--
发表时间:
1995
期刊:
The American journal of pathology
影响因子:
--
作者:
Kulkarni,AB;Ward,JM;Yaswen,L;Mackall,CL;Bauer,SR;Huh,CG;Gress,RE;Karlsson,S
通讯作者:
Karlsson,S
影响因子:
--
作者:
Agatha Kokot;A. Sindrilaru;M. Schiller;C. Sunderkötter;C. Kerkhoff;B. Eckes;K. Scharffetter;T. Luger;M. Böhm
通讯作者:
M. Böhm
影响因子:
29.4
作者:
Meng F;Wang K;Aoyama T;Grivennikov SI;Paik Y;Scholten D;Cong M;Iwaisako K;Liu X;Zhang M;Österreicher CH;Stickel F;Ley K;Brenner DA;Kisseleva T
通讯作者:
Kisseleva T
影响因子:
29.4
作者:
F. Rieder;Shardul Bhilocha;A. Schirbel;Zhufeng Ouyang;G. West;A. Atreja;H. Rho;C. Motte;C. Fiocchi
通讯作者:
C. Fiocchi
影响因子:
6.7
作者:
Bruns, Tony;Peter, Jack;Stallmach, Andreas
通讯作者:
Stallmach, Andreas